We analyzed somatic BRCA1 status in hereditary ovarian cancers undergoing short-term preoperative therapy (on average, 3 cycles of platinum-containing cocktails given with 21-day intervals). The gene discussed is BRCA1; the disease is ovarian carcinoma.